1. Home
  2. AVNW vs NKTX Comparison

AVNW vs NKTX Comparison

Compare AVNW & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aviat Networks Inc.

AVNW

Aviat Networks Inc.

HOLD

Current Price

$21.97

Market Cap

274.4M

Sector

Technology

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$1.88

Market Cap

133.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNW
NKTX
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
274.4M
133.5M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
AVNW
NKTX
Price
$21.97
$1.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$32.50
$13.25
AVG Volume (30 Days)
115.5K
641.1K
Earning Date
11-04-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
$453,497,000.00
N/A
Revenue This Year
$5.73
N/A
Revenue Next Year
$6.79
N/A
P/E Ratio
$21.32
N/A
Revenue Growth
10.72
N/A
52 Week Low
$15.80
$1.31
52 Week High
$26.83
$2.74

Technical Indicators

Market Signals
Indicator
AVNW
NKTX
Relative Strength Index (RSI) 50.99 47.98
Support Level $20.81 $1.78
Resistance Level $21.38 $1.90
Average True Range (ATR) 0.80 0.07
MACD 0.12 0.02
Stochastic Oscillator 73.33 73.91

Price Performance

Historical Comparison
AVNW
NKTX

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: